mddperspectives.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | BioWorld: The Daily Biopharmaceutical and Medical Technology News |
| Description | BioWorld. Link to Daily news and analysis of the global biotechnology, pharmaceutical and medical technology |
| Keywords | news, analysis, biotech, biotechnology, pharma, pharmaceutical, health, business, medtech, medical technology, devices, diagnostics, financing, regulation, science, innovation, drug approvals, FDA, EMA, clinical trials, partnerships |
Server Information
| WebSite | |
| Host IP | 72.52.10.14 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
mddperspectives.com Valuation
|
US$1,005
Last updated: 2023-05-13 03:11:51
mddperspectives.com has Semrush global rank of 0. mddperspectives.com has an estimated worth of US$ 1,005, based on its estimated Ads revenue. mddperspectives.com receives approximately 116 unique visitors each day. Its web server is located in United States, with IP address 72.52.10.14. According to SiteAdvisor, mddperspectives.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,005 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$27 |
| Yearly Ads Revenue | US$334 |
| Daily Unique Visitors | 7 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| mddperspectives.com. | A | 86400 | IP: 72.52.10.14 |
| mddperspectives.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
| mddperspectives.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
| mddperspectives.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
| mddperspectives.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
| mddperspectives.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
| mddperspectives.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
| mddperspectives.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
HtmlToTextCheckTime:2023-05-13 03:11:51
| All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser. More information on our cookie policy. BioWorld. Link to homepage. BioWorld BioWorld MedTech BioWorld Asia BioWorld Science Data Snapshots BioWorld BioWorld MedTech Special reports Aging Biosimilars Artificial intelligence Coronavirus IVDs on the rise Radiopharmaceuticals Science ’22 in Review Top Biopharma Trends of 2022 Top Med-tech Trends of 2022 Premium reports BioWorld Financings Reports Disease Incidence & Prevalence Summaries BioWorld. Link to homepage. sign in Sign Out My Account Subscribe BioWorld - Friday, May 12, 2023 BioWorld BioWorld MedTech BioWorld Asia BioWorld Science BioWorld US FDA approves Rexulti as first drug for agitation in Alzheimer’s dementia On its May 10 PDUFA date, the U.S. FDA approved serotonin-dopamine modulator Rexulti (brexpiprazole) from Otsuka Pharmaceutical |
HTTP Headers
HTTP/1.1 301 Moved Permanently cache-control: no-cache, no-store, must-revalidate Pragma: no-cache Expires: -1 X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff X-Frame-Options: DENY Content-Security-Policy: script-src 'self' Location: http://www.medicaldevicedaily.com Vary: Accept Content-Type: text/plain; charset=utf-8 Content-Length: 67 Date: Mon, 20 Dec 2021 13:59:18 GMT Connection: keep-alive Set-Cookie: NSC_us_nbsl-83+63+21+25-91=ffffffff2fe39b9845525d5f4f58455e445a4a423660;path=/;httponly HTTP/1.1 301 Moved Permanently cache-control: no-cache, no-store, must-revalidate Pragma: no-cache Expires: -1 X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff X-Frame-Options: DENY Content-Security-Policy: script-src 'self' Location: https://www.bioworld.com Vary: Accept Content-Type: text/plain; charset=utf-8 Content-Length: 58 Date: Mon, 20 Dec 2021 13:59:18 GMT Connection: keep-alive Set-Cookie: NSC_us_nbsl-83+63+21+25-91=ffffffff2fe39b9845525d5f4f58455e445a4a423660;path=/;httponly HTTP/1.1 200 OK Server: nginx Date: Mon, 20 Dec 2021 13:59:18 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive Vary: Accept-Encoding X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff ETag: W/"5b22c203c70cd61ad021854eb695a9d2" Cache-Control: max-age=0, private, must-revalidate, private Strict-Transport-Security: max-age=31536000 Age: 265 Via: 1.1 varnish Vary: Accept-Encoding, User-Agent X-Cache: HIT Allow-Ranges: bytes X-Frame-Options: SAMEORIGIN Content-Security-Policy: frame-ancestors 'self' continuum.epublishing.com *.continuum.epublishing.com |
mddperspectives.com Whois Information
Domain Name: MDDPERSPECTIVES.COM Registry Domain ID: 1654761259_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-04-04T09:07:54Z Creation Date: 2011-05-06T16:47:11Z Registry Expiry Date: 2022-05-06T16:47:11Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T08:14:58Z <<< |